BAK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Braskem SA (BAK) is not a strong buy for a beginner investor with a long-term strategy at this time. Despite the recent price surge, the company's financial performance is weak, analysts have downgraded the stock, and there are no significant positive catalysts to support a long-term investment. Holding off for now is recommended.
The stock shows bullish momentum with MACD above 0 and positively expanding, RSI at 84.507 indicating overbought conditions, and bullish moving averages (SMA_5 > SMA_20 > SMA_200). However, the stock is trading near resistance levels, suggesting limited short-term upside.
Braskem reported a 7% increase in Q4 polypropylene sales volume in the U.S. and Europe, indicating some operational improvements in international markets.
Analysts have downgraded the stock, citing valuation concerns and challenges in the petrochemicals market.
Q4 resin sales volume in Brazil declined by 8%.
The average utilization rate of Brazil's petrochemical plants was only 59% in Q4, reflecting operational inefficiencies.
In Q3 2025, Braskem's revenue dropped by 17.18% YoY, net income plummeted by 95.54% YoY, EPS fell by 92.31% YoY, and gross margin declined by 76.18% YoY. These figures indicate significant financial struggles.
Citi downgraded the stock to Sell from Neutral, citing valuation concerns and challenges in the petrochemicals market. BofA lowered the price target to $3.30 from $3.70, citing negative implications from recent legislative changes in Brazil.
